Ekso Bionics (NASDAQ:EKSO) Price Target Lowered to $9.00 at HC Wainwright

Ekso Bionics (NASDAQ:EKSO) had its price target cut by HC Wainwright from $10.00 to $9.00 in a research note released on Tuesday, Benzinga reports. They currently have a buy rating on the stock.

Separately, StockNews.com started coverage on shares of Ekso Bionics in a research note on Saturday. They set a “hold” rating on the stock.

Ekso Bionics Price Performance

Shares of NASDAQ:EKSO opened at $0.96 on Tuesday. The company has a market cap of $17.45 million, a P/E ratio of -0.99 and a beta of 1.45. The business has a fifty day simple moving average of $1.11 and a 200-day simple moving average of $1.15. Ekso Bionics has a 52 week low of $0.83 and a 52 week high of $3.13. The company has a quick ratio of 1.77, a current ratio of 2.42 and a debt-to-equity ratio of 0.36.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, October 28th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.02). The business had revenue of $4.13 million during the quarter, compared to analysts’ expectations of $6.00 million. Ekso Bionics had a negative net margin of 68.41% and a negative return on equity of 92.08%. During the same quarter last year, the firm earned ($0.24) EPS. Equities research analysts forecast that Ekso Bionics will post -0.42 EPS for the current year.

Institutional Trading of Ekso Bionics

A hedge fund recently raised its stake in Ekso Bionics stock. Kent Lake Capital LLC grew its holdings in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 322.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 596,050 shares of the company’s stock after buying an additional 454,892 shares during the quarter. Kent Lake Capital LLC owned 3.28% of Ekso Bionics worth $811,000 at the end of the most recent quarter. 6.42% of the stock is currently owned by institutional investors and hedge funds.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.